Our patent pending technology automatically kills germs on public touch points within 5 seconds after each touch

Preventing the spread of infectious disease. In a clinical trial, our chemical-free solution
killed the COVID-19 virus in 1 second!

Problem

54,000 people die prematurely every day due to preventable illnesses and 80% of the most common infectious diseases are spread by the hands through germ-infested public touch points such as door handles, restroom stalls, elevators, and ATMs

Our solution

Our product forms a sealed germ decontamination chamber around existing public touch points. After each touch, the chamber automatically seals allowing UVC LED light to automatically decontaminate the surface in less than 5 seconds.

Target Market

Our technology provides immediate relief to a $38b unaddressed US market for surface-based public germicidal infrastructure.
In phase 1, we are targeting healthcare-related institutions, k-12 schools, cruise lines, and casinos.

OUR STORY

2019

Launched

6

Months before COVID-19

1500000

Germs Killed

5

Seconds

WHO IS
MICROLUMIX

The company you have never heard of today. The company you will never forget tomorrow

We launched in September of 2019 and incorporated on 1/1/2020. We tested our first working concept model two weeks before COVID-19 hit the US and we killed 1.5 million germs from a door handle in 5 seconds. Since then, we have killed more than a billion germs in testing.

It's Much Bigger Than

COVID-19

  • COVID-19
  • Meningitis
  • MRSA
  • Gastrointestinal infections
  • Hepatitis B

Touch points realated

Infectious Diseases

  • Norovirus (winter flu)
  • E-coli
  • Klebsiella pneumoniae
  • Streptococcus (per Mayo Clinic)
  • Viral infections

SICKNESS COSTS EVERYONE

Looking at the data to see if there is a financial impact that would provide sufficient motivation to acquire our technology. In the US alone, absenteeism costs employers $260b annually. Healthcare-Associated Infections cost another $55b. Medical visits and hospitalizations due to preventable illnesses another $200b.

These factors alone account for $1/2 trillion and this is just within the US. We expect to reduce all these issues significantly and add billions back to the bottom line of public and privately-held organizations around the world.

Employee Absenteeism 260B
Preventable Medical Costs 200B
Hospital Associated Infections 55B
Watch the full launching event